Description
Novel pharmacological and biological approaches to disease are calling for novel systems of delivering therapies. This has focused attention on the market for drug delivery systems and the pharmaceuticals that are sold along with those technologies. Kalorama’s Drug Delivery Systems focuses on these technologies.
This offer is for the entire 4 volumes of Kalorama’s 2nd edition of its Drug Delivery Markets series, covering all major types, including:
- Oral Delivery
- Implantable/Injectable
- Pulmonary
- Transdermal/Transmucosal
While oral delivery remains the most popular and cost-effective methods, implantable and injectable and pulmonary methods are options for fast distribution and stronger dosage. Transdermal patches and new electric transfers allow painless entry for medicines that cannot be administered orally.
Kalorama’s Drug Delivery Markets series provides exhaustive coverage of four key areas of drug delivery.
As part of Kalorama’s trusted information-gathering process, over 70 industry executives in the drug delivery area were interviewed, along with through research of public information, medical journals and company reports. Interviews provide the basis of forecasts.
Table of Contents
Drug Delivery Markets, Vol I: Oral Delivery
Chapter one: Executive Summary
- Market Drivers
- Market Size and Growth
- Total Oral Drug Delivery Market
- Oral Drug Delivery Technology Only Market
- Competitive and Market Analysis
Chapter two: Introduction and Overview
- Scope of the Report
- Methodology
- History of Oral Drug Delivery
- Phases of Drug Action
- Barriers to Oral Drug Delivery
- Controlled-Release/Sustained-Release
- Delayed Release and Modified Release
- Fast Dissolving
- Taste-Masked
- Pulsatile Release
- Microemulsion and Others
Chapter three: Key Trends and Demographics
- The Elderly
- Regulatory Environment
- Patent Protection and Extension
- Earlier Involvement
- Consolidation
- Proprietary Product Development
- Implications for Generic and Over-the-Counter Products
- Pharmaceutical Formulation
Chapter four: New Developments
- Macromolecule Delivery
- Delivery of Hydrophobic Drugs
- Other Delivery Solutions
Chapter five: Market Size and Growth
- The Total Oral Drug Delivery Market
- Oral Delivery Technology Only Market
Chapter six: Competitive Analysis
Competitive Landscape
Chapter seven: Company Profiles
- ALZA Corporation
- Andrx Pharmaceuticals
- Biovail Corporation
- Cardinal Health
- Elan Corporation, plc
- Emisphere Technologies, Inc.
- KV Pharmaceutical
- Labopharm, Inc.
- Penwest Pharmaceutical Company
- Purdue/MundiPharma/Napp Group
- SkyePharma PLC
Chapter eight: Companies in Brief
- Alkermes, Inc.
- Astellas
- BioProgress Technologies International, Inc.
- CIMA Labs, Inc. Division of Cephalon
- DepoMed, Inc.
- Endorex, Inc.
- Eurand, Inc.
- Kos Pharmaceuticals, Inc.
- Lipocine, Inc.
Appendix: Company Directory
List of Exhibits
Chapter one: Executive Summary
Chapter two: Introduction and Overview
- Table 2-1: Selected Types of Oral Solid Preparations
- Table 2-2: Sequence of Drug Action
Chapter three: Key Trends and Demographics
- Table 3-1: World Population by Age Group 2002-2010
- Figure 3-1: World Population by Age Group 2002-2010
- Table 3-2: Recent Consolidations in the Drug Delivery Market
Chapter four: New Developments
Chapter five: Market Size and Growth
- Table 5-1: The Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals Revenues and Growth Rate 2002-2010
- Figure 5-1: Trending in the Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals 2002-2010
- Table 5-2: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type 2002-2010
- Figure 5-2: Trending in the Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type 2002-2010
- Table 5-3: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Market Share by Type 2002-2010
- Table 5-4: The Worldwide Market for Oral Drug Delivery Systems by Pharmaceutical vs Drug Delivery Components 2002-2010
- Table 5-5: The Worldwide Market for Oral Drug Delivery Systems Distribution of Revenue by Pharmaceutical vs Drug Delivery Component 2002-2010
- Figure 5-3: The Worldwide Market for Oral Drug Delivery Systems Share of Revenue by Pharmaceutical and Drug Delivery Component 2006, 2010
Chapter six: Competitive Analysis
- Table 6-1: Leading Suppliers of Oral Drug Delivery Technology (Company, Proprietary Technology, Approved Products)
Drug Delivery Markets, 2nd Edition, Vol II: Implantable / Injectable Delivery Systems
Chapter one: Executive Summary
- Market Drivers
- Market Size and Growth
- Total Injectable/Implantable Drug Delivery Market
- The Injectable/Implantable Drug Delivery Only Market
- Competitor and Market Analysis
Chapter two: Introduction
- Scope and Methodology
- Reasons for Injectable/Implantable Drug Delivery Systems
- History of Injectable/Implantable Drug Delivery
- Phases of Drug Action
- Needle-Free Drug Delivery
- Major Applications
- Safety Concerns
- Products
- Implantable Drug Delivery
- Mechanisms
- Applications
- Products
- Sustained-Release Drug Delivery
- Targeted Injection Drug Delivery
Chapter three: Trends and Developments
- Drivers of the Injectable/Implantable Drug Delivery Market
- Pen injectors
- Proprietary Product Development
- Delivery Systems Placement Trends
- Therapeutic Trends
- Incorporation of Technology
- Nanotechnology
- Drug Delivery Development
- Microsphere Technology
- Targeted Technology
- MicroChip Technology
- NanoParticles
- Protein-Coated Microcrystal Technology
- Needle-Free Delivery Development
- Selected Products in Development
Chapter four: Market Size and Growth
- The Total Injectable/Implantable Drug Delivery Market
- Injectable/Implantable Delivery Technology Only Market
chapter five: Competitive and Market Analysis
- Competitive Landscape
- Market Analysis
Chapter six: Company Profiles
- Alkermes, Inc.
- ALZA Corp.
- Antares Pharma, Inc.
- Bioject Medical Technologies, Inc.
- CyDex, Inc.
- MGI Pharma, Inc
- Nektar Therapeutics
- PowderMed Pharmaceuticals Plc
- SkyePharma Plc
- Zogenix Corporation
Chapter seven: Companies in Brief
- AP Pharma
- Baxter BioPharma Solutions
- ImaRx Therapeutics Inc.
- PR Pharmaceuticals, Inc.
- pSivida
- QLT USA, Inc
Appendix: Company Directory
TABLE OF EXHIBITS
Chapter one: Executive Summary
- Figure 1-1: The Worldwide Market for Injectable/Implantable
- Drug Delivery Technology and Pharmaceuticals 2002-2010
Chapter two: Introduction
- Table 2-1: Sequence of Drug Action
Chapter three: Trends and Developments
- Table 3-1: Select Products in Early Stage Development by Drug
- Delivery Companies
Chapter four: Market Size and Growth
- Table 4-1: Worldwide Market for Injectable/Implantable Drug Delivery Technology and Pharmaceuticals 2002-2010
- Figure 4-1: Worldwide Market for Injectable/Implantable Drug Delivery Technology and Pharmaceuticals 2002-2010
- Table 4-2: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery by Type 2002-2010
- Figure 4-2: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery by Type 2002-2010
- Table 4-3: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery Market Share by Type 2002-2010
- Figure 4-3: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery Market Share by Type 2006
- Figure 4-4: Worldwide Market for Pharmaceuticals Utilizing Injectable/ Implantable Drug Delivery Market Share by Type 2010
- Table 4-4: Worldwide Market for Injectable/Implantable Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2002-2010
- Table 4-5: Injectable/Implantable Drug Delivery Systems: Worldwide Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
- Figure 4-5: Injectable/Implantable Drug Delivery Systems Worldwide Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2006
- Figure 4-6: Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010
chapter five: Competitive and Market Analysis
- Table 5-1: Leading Suppliers of Injectable/Implantable Drug Delivery Technology
- Figure 5-1: Cost per Million Injections by Injector Type
Drug Delivery Markets, Vol III: Pulmonary Delivery Systems
Chapter one: Executive Summary
- Market Drivers
- Market Size and Growth
- The Total Pulmonary Drug Delivery Market
- The Total Pulmonary Drug Delivery Only Market
- Competitor and Market Analysis
Chapter two: Introduction and Overview
- Scope and Methodology
- Reasons for pulmonary Drug Delivery Systems
- History and Mechanics of Pulmonary Drug Delivery
- Phases of Drug Action
- Pharmacokinetics of Inhalation
- Inhalation Delivery Technologies
- Metered Dose Inhalers
- Dry Powder Formulations
- Nebulizer Delivery Formulations
- Liquid Formulations
- Nanospheres
- Intranasal Delivery Technologies
Chapter three: Trends and Demographics
- Asthma
- Opportunities for Drug Delivery System Success
- Exubera Breakthrough
- Nano and Microparticulate Systems
- Trends in Liquid Aerosols
- CFC Phase Out
- Expansion of Biotechnology
- Macromolecule Delivery
Chapter four: New Developments
- Prodrug Drug Delivery
- Electrohydrodynamic Aerosol Delivery
- Oxygen Delivery
- Crystallization Technology
Chapter five: Market Size and Growth
- The Total Pulmonary Drug Delivery Market
- Pulmonary Delivery Technology Only Market
Chapter six: Competitive and Market Analysis
- Competitor Analysis
- Market Analysis
Chapter seven: Company Profiles
- 3M Pharmaceuticals
- Alkermes, Inc.
- Aradigm Corporation
- Elan Corporation, Plc
- Innovata BioMed Plc
- MicroDose Technology, Inc
- Nastech Pharmaceutical Company Inc.
- Nektar Therapeutics
- Oriel Therapeutics
- Pipex Pharmaceuticals
- Resiprics, Inc.
- SkyePharma Plc
- Vectura Ltd.
- Ventaira Pharmaceuticals, Inc.
Chapter eight: Companies in Brief
- Bespak
- Direct Haler A/S
- IntraNasal Therapeutics
Appendix: Company Directory
TAble of exhibits
Chapter one: Executive Summary
- Table 1-1: The Worldwide Market for Pulmonary Drug Delivery Technology and Pharmaceuticals 2002-2010
- Figure 1-1: The Worldwide Market for Pulmonary Drug Delivery Technology and Pharmaceuticals 2002-2010
- Table 1-2: The Worldwide Market for Pulmonary Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2002-2010
- Figure 1-2: The Worldwide Market for Pulmonary Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
Chapter two: Introduction and Overview
- Table 2-1: Sequence of Drug Action
Chapter three: Trends and Demographics
- Table 3-1: Worldwide Prevalence of Asthma 2006
- Figure 3-1: Worldwide Prevalence of Asthma 2006
- Table 3-2: World Population by Age Group 2002-2010
- Figure 3-2: World Population by Age Group 2002-2010
Chapter fivE: Market Size and Growth
- Table 5-1: The Worldwide Market for Pulmonary Drug Delivery Technology and Pharmaceuticals 2002-2010
- Figure 5-1: The Worldwide Market for Pulmonary Drug Delivery Technology and Pharmaceuticals 2002-2010
- Table 5-2: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug Delivery Systems by Type 2002-2010
- Figure 5-2: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug Delivery Systems Revenues by Type 2002-2010
- Table 5-3: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug Delivery Technologies Market Share by Type 2002-2010
- Figure 5-3: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug Delivery Technologies by Type 2006
- Figure 5-4: The Worldwide Market for Pharmaceuticals Utilizing Pulmonary Drug Delivery Technologies by Type 2010
- Table 5-4: The Worldwide Market for Pulmonary Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2002-2010
- Table 5-5 of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
- Figure 5-5 of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
- Figure 5-6: The Worldwide Market for Pulmonary Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2006
- Figure 5-7: The Worldwide Market for Pulmonary Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010
Chapter six: Competitive and Market Analysis
- Table 6-1: Selected Leading and Emerging Suppliers of Pulmonary Drug
- Delivery Technology
Drug Delivery Markets, Vol. IV: Transdermal
Chapter One: Executive Summary
- Market Drivers
- Market Size and Growth
- Total Transdermal/Transmucosal Drug Delivery Market
- Transdermal/Transmucosal Drug Delivery Only Market
- Competitive and Market Analysis
Chapter Two: Introduction and Overview
- Scope and Methodology
- Reasons for Transdermal/Transmucosal Drug Delivery Systems
- History of Transdermal and Transmucosal Drug Delivery
- Phases of Drug Action
- Topical Drug Delivery
- Types of Topical Preparations
- Market Participants
- Transdermal Patch Drug Delivery
- Membrane-Controlled System
- Adhesive Dispersion-Type System
- Matrix Diffusion-Controlled System
- Microreservoir Dissolution-Controlled System
- New Transdermal Drug Applications and Approvals
- Electrotransport Drug Delivery
- Iontophoresis
- Transmucosal Drug Delivery
- Oral Transmucosal Fentanyl Citrate (OTFC)
- Transmucosal Etomidate
- Ondansetron ODT
- Buccal Drug Delivery
- Vaginal Drug Delivery
Chapter three: Trends and Developments
- Innovations in Transdermal Drug Delivery
- Adhesive Technology and Issues
- Adhesive Market Issues
- Biotechnological Issues
- Iontophoresis and Sonophoresis
- Developments in Insulin Delivery
- New Developments in Hormone Drug Delivery
- New Mucosal/Buccal Delivery Systems
- Other New Drug Delivery Systems
- Macroflux Technology
- Controlled Thermal Energy Technology
- New Ultrasound Technology
- Combination Delivery Technology
- Transdermal Products in Development
Chapter four: Market Size and Growth
- The Total Transdermal/Transmucosal Drug Delivery Market
- Transdermal/Transmucosal Delivery Technology Only Market
chapter five: Competitive Analysis
- Competitive Landscape
- Market Analysis
CHAPTER SIX: Company Profiles
- 3M Pharmaceuticals
- Acrux Limited
- Altea Therapeutics, Inc
- ALZA Corporation
- Antares Pharma, Inc.
- Aveva Drug Delivery Systems
- Cardinal Health
- Cephalon Inc
- Generex Biotechnology Corporation
- Inovio Biomedical Corporation
- Labtec GmbH
- Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG)…………….
- MacroChem Corporation
- NexMed, Inc.
- Noven Pharmaceuticals, Inc.
- SkyePharma PLC
Appendix
Company Directory
Table of exhibits
chapter twO: Introduction and Overview
- Table 2-1: Sequence of Drug Action
Chapter three: Trends and Developments
- Table 3-1: Selected Transdermal Products in Development
Chapter four: Market Size and Growth
- Table 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and Pharmaceuticals 2002-2010
- Figure 4-1.. : The Worldwide Market for Transdermal/Transmucosal Drug Delivery Technology and Pharmaceuticals 2002-2010
- Table 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Systems by Type 2002-2010
- Figure 4-2: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Systems Revenues by Type 2002-2010
- Table 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Technologies Market Share by Type 2002-2010…….
- Figure 4-3: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Technologies by Type 2006
- Figure 4-4: The Worldwide Market for Pharmaceuticals Utilizing Transdermal/ Transmucosal Drug Delivery Technologies by Type 2010
- Table 4-4: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems by Pharmaceutical and Drug Delivery Component 2002-2010
- Table 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
- Figure 4-5.. : The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2002-2010
- Figure 4-6: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2006
- Figure 4-7: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component 2010
chapter five: Competitive Analysis
- Table 5-1: Leading Suppliers of Transdermal/Transmucosal Drug Delivery Technology
